MIRIKIZUMAB IMPROVES PATIENT ASSESSMENT OF DISEASE SEVERITY AND CHANGE IN DISEASE ACTIVITY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE

被引：0
|
作者：
Rubin, David
Pollack, Paul
Hunter, Theresa
Shan, Mingyang
Chan, Lai-Shan
Deckard, Deanilee
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：S14 / S15
页数：2
相关论文
共 50 条
  • [21] Mirikizumab for Crohn's disease
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (02): : 117 - 117
  • [22] Mirikizumab for Crohn's disease
    Feetham, Laura
    Brierley, Rob
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (08): : 583 - 583
  • [23] Characterisation of endoscopic improvements with risankizumab treatment in patients with moderately to severely active Crohn's disease
    Reinisch, W.
    Colombel, J. F.
    Ma, C.
    Long, M.
    Irving, P. M.
    O'Brien, D.
    Kligys, K.
    Song, A.
    Zhang, Y.
    D'Haens, G.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1378 - I1379
  • [24] Efficacy of Induction upadacitinib Therapy in Chinese Patients with Moderately to Severely Active Crohn's Disease
    Chen, M.
    Gao, X.
    Cao, Q.
    Zhang, X.
    Chen, Y.
    Hou, X.
    Zhong, J.
    Sun, Y.
    Phaleng, X.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1213 - I1213
  • [25] Sustained Remission with Adalimumab Therapy in Japanese Patients with Moderately to Severely Active Crohn's Disease
    Hibi, Toshifumi
    Watanabe, Mamoru
    Kumar, Ashish
    Camez, Anne
    Lomax, Kathleen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S463 - S463
  • [26] Improvement in Fatigue With Mirikizumab Therapy Is Associated With Clinical Remission and Pain Improvements but Not With Endoscopic Response in Patients With Moderately-to-Severely Active Crohn's Disease
    Regueiro, Miguel
    Fischer, Monika
    Rubin, David T.
    Hibi, Toshifumi
    Bossuyt, Peter
    Juillerat, Pascal
    Pollack, Paul
    Zhou, Xian
    Protic, Marijana
    Gibble, Theresa Hunter
    Chan, Lai-Shan
    Carlier, Hilde
    Hindryckx, Pieter
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S602 - S603
  • [27] Impact of Mirikizumab Therapy on Histologic Measures of Intestinal Inflammation in a Phase 2 Study of Patients With Moderately- to Severely-Active Crohn's Disease
    Pai, Rish
    De Hertogh, Gert
    Reinisch, Walter
    Harpaz, Noam
    Feagan, Brian G.
    Agada, Noah
    Pollack, Paul
    Chan, Lai Shan
    Protic, Marijana
    Magro, Fernando
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S421 - S422
  • [28] Corticosteroid discontinuation and clinical outcomes in patients with moderately to severely active Crohn's disease treated with upadacitinib
    Thin, L.
    Dubinsky, M.
    D'Haens, G.
    Dewit, O.
    Juillerat, P.
    Panaccione, R.
    Fujii, T.
    Lacerda, A.
    Dubcenco, E.
    Anyanwu, S.
    Doshi, C.
    Mallick, M.
    Garrison, A.
    Liu, J.
    Loftus, E., Jr.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 127 - 128
  • [29] Clinical Benefit of Adalimumab Dose Adjustment for Patients With Moderately to Severely Active Crohn's Disease in EXTEND
    Colombel, Jean-Frederic
    Rutgeerts, Paul
    Sandborn, William
    Wolf, Douglas
    Reinisch, Walter
    Van Assche, Gert
    Eichner, Samantha
    Zhou, Qian
    Petersson, Joel
    Robinson, Anne
    Thakkar, Roopal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S474 - S474
  • [30] Corticosteroid-Sparing Effect of Upadacitinib in Patients With Moderately-to-Severely Active Crohn's Disease
    Dubinsky, Marla C.
    D'Haens, Geert
    Dewit, Olivier
    Juillerat, Pascal
    Panaccione, Remo
    Fujii, Toshimitsu
    Lacerda, Ana P.
    Dubcenco, Elena
    Anyanwu, Samuel I.
    Doshi, Chirag
    Liu, Jianzhong
    Garrison, Andrew
    Loftus, Edward V.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S886 - S887
12345